Want to see HK:2530 full AI Analyst Report?
Numans Health Food Holdings Company Limited (2530) AI Stock Analysis
Numans Health Food Holdings Company Limited
(HKEX:2530)
The overall score reflects a financially safe company with a strong, low-leverage balance sheet and historically solid cash generation that is now under material operational pressure from falling sales and compressed margins, while neutral technical signals and a relatively attractive valuation provide support but are insufficient to offset the business downturn.
Numans Health Food Holdings Company Limited (2530) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 700.00M
- Dividend Yield
- 3.57%
- Average Volume (3M)
- 466.92K
- Price to Earnings (P/E)
- 7.6
- Beta (1Y)
- 0.17
- Revenue Growth
- -22.46%
- EPS Growth
- 72.17%
- Country
- Hong Kong
- Employees
- 50
- Sector
- General
- Sector Strength
- 55
- Industry
- Packaged Foods
Numans Health Food Holdings Company Limited Business Overview & Revenue Model
Company Description
Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexaenoic acid (D...
How the Company Makes Money
null
Numans Health Food Holdings Company Limited Financial Statement Overview
Summary
Revenue and earnings have declined sharply with margins compressed to low single digits, but this is partially offset by a very strong, low-debt balance sheet and historically solid, though now weakening, cash generation, resulting in a slightly below-average overall financial profile.
Income Statement
38NegativeBalance Sheet
82Very PositiveCash Flow
74Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 251.03M | 184.44M | 282.57M | 426.82M | 375.05M | 332.03M |
| Gross Profit | 156.17M | 122.78M | 210.81M | 316.17M | 274.05M | 239.01M |
| EBITDA | 19.84M | 14.05M | 101.40M | 194.32M | 118.40M | 157.89M |
| Net Income | 77.89M | 5.36M | 76.27M | 159.45M | 89.37M | 117.69M |
Balance Sheet | ||||||
| Total Assets | 552.40M | 513.74M | 415.59M | 470.02M | 403.58M | 288.81M |
| Cash, Cash Equivalents and Short-Term Investments | 444.41M | 401.65M | 235.82M | 262.56M | 192.84M | 152.66M |
| Total Debt | 4.99M | 3.77M | 4.43M | 5.83M | 7.45M | 1.23M |
| Total Liabilities | 44.01M | 18.40M | 39.07M | 59.94M | 156.34M | 86.29M |
| Stockholders Equity | 508.38M | 495.34M | 376.52M | 410.08M | 247.24M | 202.52M |
Cash Flow | ||||||
| Free Cash Flow | 56.87M | 46.71M | 82.33M | 149.95M | 39.42M | 93.00M |
| Operating Cash Flow | 57.07M | 46.75M | 83.46M | 150.57M | 44.31M | 93.99M |
| Investing Cash Flow | -117.64M | -37.02K | 2.04M | 1.57M | -4.14M | -519.00K |
| Financing Cash Flow | -76.07M | 116.27M | -113.48M | -83.79M | -8.55M | -29.31M |
Numans Health Food Holdings Company Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2530, the sentiment is Negative. The current price of 0.70 is below the 20-day moving average (MA) of 0.71, below the 50-day MA of 0.72, and above the 200-day MA of 0.66, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 46.49 is Neutral, neither overbought nor oversold. The STOCH value of 71.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2530.
Numans Health Food Holdings Company Limited Peers Comparison
Overall Rating
HK:183773Outperform
HK:149765Neutral
HK:111264Neutral- HK:253062Neutral
HK:686861Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1837 | 73Outperform | HKD 2.98B | 7.96 | 18.48% | 5.07% | 33.56% | 59.06% |
| HK:1497 | 65Neutral | HKD 3.55B | 11.48 | 27.00% | 9.40% | 12.12% | 32.06% |
| HK:1112 | 64Neutral | HKD 15.51B | 17.69 | 11.77% | 4.08% | 24.27% | ― |
| HK:2530 | 62Neutral | HKD 700.00M | 7.62 | 15.52% | 3.57% | -22.46% | 72.17% |
| HK:6868 | 61Neutral | HKD 2.80B | 19.87 | 6.79% | 4.23% | -7.14% | 5.00% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2530 | Numans Health Food Holdings Company Limited | 0.70 | 0.10 | 16.67% | |
| HK:1112 | Health and Happiness (H&H) International Holdings | 24.02 | 12.47 | 108.06% | |
| HK:6868 | Tenfu (Cayman) Holdings Co | 2.60 | -0.23 | -8.26% | |
| HK:1837 | Natural Food International Holding Ltd. | 1.36 | 0.27 | 24.20% | |
| HK:1497 | Xiamen Yan Palace Bird's Nest Industry Co., Ltd. Class H | 5.90 | -0.92 | -13.53% | |
| HK:6980 | Bama Tea Co. Ltd. Class H | 19.70 | -64.51 | -76.61% |
Numans Health Food Holdings Company Limited Corporate Events
Numans Health Food Swings to Strong Interim Profit Despite Revenue Decline
Numans Health Food Holdings Company Limited reported interim unaudited results for the six months ended 30 June 2026, showing revenue of RMB72.7 million, down from RMB93.2 million a year earlier. The health food group nevertheless delivered a sharp t...
Numans Health Food shifts Hong Kong principal office to Wan Chai
Numans Health Food Holdings Company Limited has relocated its principal place of business in Hong Kong to Suite 2407 on the 24th floor of China Resources Building on Harcourt Road in Wan Chai, effective 24 August 2026. While telephone and facsimile c...
Numans Health Food Sets August Board Meeting to Approve Interim Results
Numans Health Food Holdings Company Limited has scheduled a board meeting for 28 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider the possible recommendation of an interim divid...
Numans Health Food Signals Higher Profit on Lower Revenue in Supplemental Alert
Numans Health Food Holdings Company Limited has issued a supplemental positive profit alert, indicating that while revenue from its nutritional products business fell to about RMB72.7 million from RMB93.2 million year-on-year, profit for the period,...
Numans Health Food Flags Surge in Interim Profit on Investment Gains
Numans Health Food Holdings Company Limited has warned investors of a sharp jump in interim profit, with the group expecting net profit of about RMB48.9 million for the six months ended 30 June 2026, compared with RMB2.1 million a year earlier. The c...
Numans Health Food Wins Waiver on Circular Delay for Further Acquisitions
Numans Health Food Holdings Company Limited has secured a waiver from strict compliance with Rule 14.41(a) of the Hong Kong Listing Rules, allowing additional time to finalize financial information required for a circular on its planned further acqui...
Numans Health Food Details Auditor Change and Delay in 2025 Results
Numans Health Food Holdings Company Limited has detailed the timeline and circumstances surrounding its change of auditor and the resulting delay in publishing its 2025 annual results. The company explained that Crowe, appointed as auditor in Septemb...
Numans Health Food delays acquisition circular, seeks waiver on disclosure deadline
Numans Health Food Holdings Company Limited has announced a delay in sending a shareholder circular relating to its further acquisitions, which together with previous deals amount to a major transaction under Hong Kong listing rules. The company says...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 23, 2026